Corticosteroids for patients with vestibular neuritis: An evidence synthesis for guidelines for reasonable and appropriate care in the emergency department.
Caloric test
Steroid
corticosteroids
dexamethasone
dizziness
head impulse test
methylprednisolone
nausea
vertigo
vestibular neuritis
vestibular rehabilitation
Journal
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
10
07
2022
received:
20
05
2022
accepted:
10
08
2022
medline:
12
5
2023
pubmed:
18
8
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
A short course of corticosteroids is among the management strategies considered by specialists for the treatment of vestibular neuritis (VN). We conducted an umbrella review (systematic review of systematic reviews) to summarize the evidence of corticosteroids use for the treatment of VN. We included systematic reviews of randomized controlled trials (RCTs) and observational studies that evaluated the effects of corticosteroids compared to placebo or usual care in adult patients with acute VN. Titles, abstracts, and full texts were screened in duplicate. The quality of reviews was assessed with the A MeaSurement Tool to Assess systematic Reviews (AMSTAR-2) tool. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) assessment was used to rate certainty of evidence. No meta-analysis was performed. From 149 titles, five systematic reviews were selected for quality assessment, and two reviews were of higher methodological quality and were included. These two reviews included 12 individual studies and 660 patients with VN. In a meta-analysis of two RCTs including a total of 50 patients, the use of corticosteroids (compared to placebo) was associated with higher complete caloric recovery (risk ratio 2.81, 95% confidence interval [CI] 1.32 to 6.00, low certainty). It is very uncertain whether this translates into clinical improvement as shown by the imprecise effect estimates for outcomes such as patient-reported vertigo or patient-reported dizziness disability. There was a wide CI for the outcome of dizziness handicap score (one study, 30 patients, 20.9 points in corticosteroids group vs. 15.8 points in placebo, mean difference +5.1, 95% CI -8.09 to +18.29, very low certainty). Higher rates of minor adverse effects for those receiving corticosteroids were reported, but the certainty in this evidence was very low. There is limited evidence to support the use of corticosteroids for the treatment of VN in the emergency department.
Sections du résumé
BACKGROUND
A short course of corticosteroids is among the management strategies considered by specialists for the treatment of vestibular neuritis (VN). We conducted an umbrella review (systematic review of systematic reviews) to summarize the evidence of corticosteroids use for the treatment of VN.
METHODS
We included systematic reviews of randomized controlled trials (RCTs) and observational studies that evaluated the effects of corticosteroids compared to placebo or usual care in adult patients with acute VN. Titles, abstracts, and full texts were screened in duplicate. The quality of reviews was assessed with the A MeaSurement Tool to Assess systematic Reviews (AMSTAR-2) tool. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) assessment was used to rate certainty of evidence. No meta-analysis was performed.
RESULTS
From 149 titles, five systematic reviews were selected for quality assessment, and two reviews were of higher methodological quality and were included. These two reviews included 12 individual studies and 660 patients with VN. In a meta-analysis of two RCTs including a total of 50 patients, the use of corticosteroids (compared to placebo) was associated with higher complete caloric recovery (risk ratio 2.81, 95% confidence interval [CI] 1.32 to 6.00, low certainty). It is very uncertain whether this translates into clinical improvement as shown by the imprecise effect estimates for outcomes such as patient-reported vertigo or patient-reported dizziness disability. There was a wide CI for the outcome of dizziness handicap score (one study, 30 patients, 20.9 points in corticosteroids group vs. 15.8 points in placebo, mean difference +5.1, 95% CI -8.09 to +18.29, very low certainty). Higher rates of minor adverse effects for those receiving corticosteroids were reported, but the certainty in this evidence was very low.
CONCLUSIONS
There is limited evidence to support the use of corticosteroids for the treatment of VN in the emergency department.
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
531-540Informations de copyright
© 2022 Society for Academic Emergency Medicine.
Références
Baloh RW. Clinical practice. Vestibular Neuritis. N Engl J Med. 2003;348(11):1027-1032. doi:10.1056/NEJMCP021154
Baron R, Steenerson KK, Alyono J. Acute vestibular syndrome and ER presentations of dizziness. Otolaryngol Clin North Am. 2021;54(5):925-938. doi:10.1016/J.OTC.2021.05.013
Chen L, Lee W, Chambers BR, Dewey HM. Diagnostic accuracy of acute vestibular syndrome at the bedside in a stroke unit. J Neurol. 2011;258(5):855-861. doi:10.1007/S00415-010-5853-4
Carmona S, Martínez C, Zalazar G, et al. The diagnostic accuracy of truncal ataxia and HINTS as cardinal signs for acute vestibular syndrome. Front Neurol. 2016;7(6):125. doi:10.3389/FNEUR.2016.00125
Edlow JA. Diagnosing patients with acute-onset persistent dizziness. Ann Emerg Med. 2018;71(5):625-631. doi:10.1016/J.ANNEMERGMED.2017.10.012
Edlow JA, Gurley KL, Newman-Toker DE. A new diagnostic approach to the adult patient with acute dizziness. J Emerg Med. 2018;54(4):469-483. doi:10.1016/J.JEMERMED.2017.12.024
Vestibular neuritis and labyrinthitis. UpToDate. 2022. Accessed April 26, 2022. https://www.uptodate.com/contents/vestibular-neuritis-and-labyrinthitis#H9
Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7(11):993-1000. doi:10.1016/S1474-4422(08)70221-7
Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol. 2000;247(6):435-442. doi:10.1007/S004150070172
Zhang Y, Akl EA, Schünemann HJ. Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods. 2018;10(3):312-329. doi:10.1002/JRSM.1313
Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1):15. doi:10.1186/1471-2288-11-15
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132-140. doi:10.1097/XEB.0000000000000055
Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev. 2011:CD008607. doi:10.1002/14651858.CD008607.PUB2/MEDIA/CDSR/CD008607/IMAGE_N/NCD008607-CMP-001-09.PNG
Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009;62(9):944-952. doi:10.1016/J.JCLINEPI.2008.10.012
Montori VM, Wilczynski NL, Morgan D, Haynes RB. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. BMJ. 2005;330(7482):68-71. doi:10.1136/BMJ.38336.804167.47
CADTH database search filters. Canadian Agency for Drugs and Technologies in Health 2021. Accessed November 1, 2021. https://www.cadth.ca/cadth-search-filters-database
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394. doi:10.1016/j.jclinepi.2010.04.026
Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes. J Clin Epidemiol. 2013;66(2):158-172. doi:10.1016/j.jclinepi.2012.01.012
Guyatt GH, Thorlund K, Oxman AD, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles - continuous outcomes. J Clin Epidemiol. 2013;66(2):173-183. doi:10.1016/j.jclinepi.2012.08.001
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:4008. doi:10.1136/BMJ.J4008
GRADEpro. McMaster University. 2021. Accessed June 14, 2021. https://gradepro.org/
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406. doi:10.1016/j.jclinepi.2010.07.015
Kim G, Seo JH, Lee SJ, Lee DH. Therapeutic effect of steroids on vestibular neuritis: systematic review and meta-analysis. Clin Otolaryngol. 2022;47(1):34-43. doi:10.1111/COA.13880
Goudakos JK, Markou KD, Franco-Vidal V, Vital V, Tsaligopoulos M, Darrouzet V. Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis. Otol Neurotol. 2010;31(2):183-189. doi:10.1097/MAO.0B013E3181CA843D
Peter IW, van Benthem PG, Aarts MCJ, Bruintjes TD, Grolman W, van der Heijden GJMG. Insufficient evidence for the effect of corticosteroid treatment on recovery of vestibular neuritis. Otolaryngol Head Neck Surg. 2012;147(5):826-831. doi:10.1177/0194599812457557
Leong KJ, Lau T, Stewart V, Canetti EFD. Systematic review and meta-analysis: effectiveness of corticosteroids in treating adults with acute vestibular neuritis. Otolaryngol Head Neck Surg. 2021;165(2):255-266. doi:10.1177/0194599820982910
Ariyasu L, Byl FM, Sprague MS, Adour KK. The beneficial effect of methylprednisolone in acute vestibular vertigo. Arch Otolaryngol Head Neck Surg. 1990;116(6):700-703. doi:10.1001/ARCHOTOL.1990.01870060058010
Rezaie AA, Hashemian F, Rezaie N. Corticosteroids effect on vestibular neuritis symptom relief. Pak Journal of Medical Sciences. 2006;22(4):409-411.
Shupak A, Issa A, Golz A, Kaminer M, Braverman I. Prednisone treatment for vestibular neuritis. Otol Neurotol. 2008;29(3):368-374. doi:10.1097/MAO.0B013E3181692804
Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351(4):354-361. doi:10.1056/NEJMOA033280
Jacobson GP, Newman CW. The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg. 1990;116(4):424-427. doi:10.1001/ARCHOTOL.1990.01870040046011
Goudakos JK, Markou KD, Psillas G, Vital V, Tsaligopoulos M. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014;140(5):434-440. doi:10.1001/JAMAOTO.2014.48
Kim JC, Cha WW, Chang DS, Lee HY. The effect of intravenous dexamethasone on the nausea accompanying vestibular neuritis: a preliminary study. Clin Ther. 2015;37(11):2536-2542. doi:10.1016/J.CLINTHERA.2015.09.010
Adamec I, Skorić MK, Gabelić T, et al. Intravenous dexamethasone in acute management of vestibular neuritis: a randomized, placebo-controlled, single-blind trial. Eur J Emerg Med. 2016;23(5):363-369. doi:10.1097/MEJ.0000000000000275
Yoo MH, Yang CJ, Kim SA, et al. Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial. Eur Arch Otorhinolaryngol. 2017;274(6):2443-2451. doi:10.1007/S00405-017-4556-1
Ismail EI, Morgan AE, Abdel Rahman AM. Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis. J Vestib Res. 2018;28(5-6):417-424. doi:10.3233/VES-180645
Karlberg MLÅ, Magnusson M. Treatment of acute vestibular neuronitis with glucocorticoids. Otol Neurotol. 2011;32(7):1140-1143. doi:10.1097/MAO.0B013E3182267E24
Batuecas-Caletrío A, Yañez-Gonzalez R, Sanchez-Blanco C, et al. Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy. J Neurol. 2015;262(11):2578-2582. doi:10.1007/S00415-015-7918-X
Sjögren J, Magnusson M, Tjernström F, Karlberg M. Steroids for acute vestibular neuronitis-the earlier the treatment, the better the outcome? Otol Neurotol. 2019;40(3):372-374. doi:10.1097/MAO.0000000000002106
Bergenius J, Perols O. Vestibular neuritis: a follow-up study. Acta Otolaryngol. 1999;119(8):895-899. doi:10.1080/00016489950180243
Okinaka Y, Sekitani T, Okazaki H, Miura M, Tahara T. Progress of caloric response of vestibular neuronitis. Acta Otolaryngol Suppl. 1993;503(S503):18-22. doi:10.3109/00016489309128064
Godemann F, Siefert K, Hantschke-Brüggemann M, Neu P, Seidl R, Ströhle A. What accounts for vertigo one year after neuritis vestibularis - anxiety or a dysfunctional vestibular organ? J Psychiatr Res. 2005;39(5):529-534. doi:10.1016/J.JPSYCHIRES.2004.12.006
Garro A, Nigrovic LE. Managing peripheral facial palsy. Ann Emerg Med. 2018;71(5):618-624. doi:10.1016/J.ANNEMERGMED.2017.08.039
Taylor RL, McGarvie LA, Reid N, Young AS, Halmagyi GM, Welgampola MS. Vestibular neuritis affects both superior and inferior vestibular nerves. Neurology. 2016;87(16):1704-1712. doi:10.1212/WNL.0000000000003223
Hegemann SCA, Wenzel A. Diagnosis and treatment of vestibular neuritis/neuronitis or peripheral vestibulopathy (PVP)? Open questions and possible answers. Otol Neurotol. 2017;38(5):626-631. doi:10.1097/MAO.0000000000001396
Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol. 2003;8(6):316-321. doi:10.1159/000073516
Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 2000;122(4):521-528. doi:10.1067/MHN.2000.102578
Keijzers G, Cullen L, Egerton-Warburton D, Fatovich DM. Don't just do something, stand there! The value and art of deliberate clinical inertia. Emerg Med Australas. 2018;30(2):273-278. doi:10.1111/1742-6723.12922
Tokle G, Mørkved S, Bråthen G, et al. Efficacy of vestibular rehabilitation following acute vestibular neuritis: a randomized controlled trial. Otol Neurotol. 2020;41(1):78-85. doi:10.1097/MAO.0000000000002443
Ohbayashi S, Oda M, Yamamoto M, et al. Recovery of the vestibular function after vestibular neuronitis. Acta Otolaryngol Suppl. 1993;503(S503):31-34. doi:10.3109/00016489309128067
Kitahara T, Kondoh K, Morihana T, et al. Steroid effects on vestibular compensation in human. Neurol Res. 2003;25(3):287-291. doi:10.1179/016164103101201364